Skip to main content
Figure 4 | BMC Clinical Pathology

Figure 4

From: A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy

Figure 4

Stability of abnormal tumor immunophenotype of sequential samples from a SS patients undergoing treatment. There is stable expression of dim CD4 in the tumor cells, with CD7dim(+) and CD7bright(+) populations painted red and green, respectively. The histogram on the far right shows a decrease in the CD7dim(+) population in response to pentostatin therapy. No overall decreases in tumor cell number in response to the prior Targretin, interferon or photopheresis treatments were noted.

Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us